These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16613713)

  • 21. PNAS-2: a novel gene probably participating in leukemogenesis.
    Wang HR; Gu CH; Zhu JY; Han JY; Zhong H; Chen FY; Ouyang RR
    Oncology; 2006; 71(5-6):423-9. PubMed ID: 17855796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
    Tsapis M; Lieb M; Manzo F; Shankaranarayanan P; Herbrecht R; Lutz P; Gronemeyer H
    Int J Biochem Cell Biol; 2007; 39(7-8):1500-9. PubMed ID: 17499001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes.
    Kalousek I; Brodska B; Otevrelova P; Röselova P
    Anticancer Drugs; 2007 Aug; 18(7):763-72. PubMed ID: 17581298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
    Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
    J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
    Lauten M; Fernandez-Munoz I; Gerdes K; von Neuhoff N; Welte K; Schlegelberger B; Schrappe M; Beger C
    Pediatr Blood Cancer; 2009 Apr; 52(4):459-63. PubMed ID: 19061214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of PUMA-alpha and down-regulation of PUMA-beta expression is associated with benzo(a)pyrene-induced apoptosis in MCF-7 cells.
    Tampio M; Markkanen P; Puttonen KA; Hagelberg E; Heikkinen H; Huhtinen K; Loikkanen J; Hirvonen MR; Vähäkangas KH
    Toxicol Lett; 2009 Aug; 188(3):214-22. PubMed ID: 19397966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.
    Wang Z; Rong YP; Malone MH; Davis MC; Zhong F; Distelhorst CW
    Oncogene; 2006 Mar; 25(13):1903-13. PubMed ID: 16301999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
    Wei G; Twomey D; Lamb J; Schlis K; Agarwal J; Stam RW; Opferman JT; Sallan SE; den Boer ML; Pieters R; Golub TR; Armstrong SA
    Cancer Cell; 2006 Oct; 10(4):331-42. PubMed ID: 17010674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
    Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
    Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible role of cholesterol in the susceptibility of a human acute lymphoblastic leukemia cell line to dexamethasone.
    Madden EA; Bishop EJ; Fiskin AM; Melnykovych G
    Cancer Res; 1986 Feb; 46(2):617-22. PubMed ID: 2866834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
    Neri P; Yasui H; Hideshima T; Tassone P; Raje N; Catley LP; Ishitsuka K; Blotta S; Kiziltepe T; Ocio EM; Fulciniti M; Kanekal S; Elliott GT; Munshi NC; Anderson KC
    Br J Haematol; 2006 Jul; 134(1):37-44. PubMed ID: 16803565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.
    Khalilzadeh A; Wangoo KT; Morris DL; Pourgholami MH
    Biochem Pharmacol; 2007 Aug; 74(3):407-14. PubMed ID: 17560963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid receptors and in vitro responses to glucocorticoid in acute nonlymphocytic leukemia.
    Crabtree GR; Bloomfield CD; Smith KA; McKenna RW; Peterson BA; Hildebrandt L; Munck A
    Cancer Res; 1981 Nov; 41(11 Pt 2):4853-6. PubMed ID: 7296546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of dexamethasone on Ca++-response of bone marrow lymphoblasts in acute leukemia].
    Dukhanin AS; Sergeev PV; Budaeva NN; Kushlinskiĭ NE; Erina TA; Stankevich LI
    Vopr Onkol; 1994; 40(1-3):76-80. PubMed ID: 7701798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
    Styczyński J; Wysocki M; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk A; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Neoplasma; 2002; 49(3):178-83. PubMed ID: 12098004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.